Loading...

What on earth are 'Functional Sodas', and are they the way forward?

Published
19 Sep 25
n/a
n/a
AshleighG's Fair Value
n/a
Loading
1Y
-12.4%
7D
1.1%

Author's Valuation

US$116.3524.1% overvalued intrinsic discount

AshleighG's Fair Value

The company is at an inflection point. After years of flat revenue at around $91B, it faces mounting pressure from shifting consumer preferences, health trends, and affordability concerns. At the same time, it is experimenting with new growth avenues in functional and health-focused beverages. The question for investors is whether these bets can meaningfully change the trajectory—or whether gains in new categories will simply balance out declines in its core snacks and sodas.

Catalysts

The company is pushing into functional and health-focused drinks with the acquisition of Poppi (prebiotic soda), ownership of Bubly (sparkling water), and a partnership with Celsius (including Rockstar energy drinks). These products could provide growth opportunities alongside established brands such as Pepsi, Lays/Smiths, Doritos, Quaker, Gatorade, and Lipton.

Industry Headwinds and Tailwinds

While the functional and prebiotic beverage market may grow up to ~7% over the next decade, traditional snacks and sodas face persistent health-related headwinds. The company is essentially betting that new categories can offset weakness in its legacy portfolio. However, with revenue stuck around $91B, it remains unclear whether growth in health-focused beverages will fully outweigh declines elsewhere.

Assumptions

  • Business mix: 42% beverages, 58% snacks.
  • Geographic exposure: 56% U.S..
  • Given both tailwinds (popularity of functional drinks) and headwinds (health conscious consumers), overall revenue is expected to remain broadly flat, with the mix shifting rather than the top line expanding.

Risks

  • Consumer Shifts: Health trends could accelerate, eroding demand for core brands faster than new ones can replace them.
  • Affordability: With high cost-of-living pressures, consumers may default to cheaper legacy snacks and sodas, limiting adoption of health-focused products. This could also be a tailwind for the Company if they have maintained a strong investment in their core brands.
  • Complexity and Costs: Managing a broader portfolio increases complexity and cost.
  • External Pressures: Tariffs, regulations, and strong competition—especially from Coca-Cola—may further constrain growth.

Conclusion

The business sits at a crossroads—health-focused beverages offer upside, but legacy declines, affordability pressures, and portfolio risks weigh equally. The most likely outcome is that revenue and earnings remain flat, with growth in new categories largely offsetting declines in core products.

One factor not yet considered is potential supply chain improvements. Efficiency gains in production, distribution, and logistics could lift margins even if revenue growth remains limited, providing some support to the bottom line.

Note: AshleighG is an employee of Simply Wall St.

How well do narratives help inform your perspective?

Disclaimer

The user AshleighG holds no position in NasdaqGS:PEP. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$160.43
FV
10.0% undervalued intrinsic discount
2.00%
Revenue growth p.a.
2users have liked this narrative
1users have commented on this narrative
36users have followed this narrative